Literature DB >> 21473879

Nilotinib ameliorates lipopolysaccharide-induced acute lung injury in rats.

Dina S El-Agamy1.   

Abstract

The present study aimed to investigate the effect of the new tyrosine kinase inhibitor, nilotinib on lipopolysaccharide (LPS)-induced acute lung injury (ALI) in rats and explore its possible mechanisms. Male Sprague-Dawley rats were given nilotinib (10mg/kg) by oral gavage twice daily for 1week prior to exposure to aerosolized LPS. At 24h after LPS exposure, bronchoalveolar lavage fluid (BALF) samples and lung tissue were collected. The lung wet/dry weight (W/D) ratio, protein level and the number of inflammatory cells in the BALF were determined. Optical microscopy was performed to examine the pathological changes in lungs. Malondialdehyde (MDA) content, superoxidase dismutase (SOD) and reduced glutathione (GSH) activities as well as nitrite/nitrate (NO(2)(-)/NO(3)(-)) levels were measured in lung tissues. The expression of inflammatory cytokines, tumor necrosis factor-α (TNF-α), transforming growth factor-β(1) (TGF-β(1)) and inducible nitric oxide synthase (iNOS) were determined in lung tissues. Treatment with nilotinib prior to LPS exposure significantly attenuated the LPS-induced pulmonary edema, as it significantly decreased lung W/D ratio, protein concentration and the accumulation of the inflammatory cells in the BALF. This was supported by the histopathological examination which revealed marked attenuation of LPS-induced ALI in nilotinib treated rats. In addition, nilotinib significantly increased SOD and GSH activities with significant decrease in MDA content in the lung. Nilotinib also reduced LPS mediated overproduction of pulmonary NO(2)(-)/NO(3)(-) levels. Importantly, nilotinib caused down-regulation of the inflammatory cytokines TNF-α, TGF-β(1) and iNOS levels in the lung. Taken together, these results demonstrate the protective effects of nilotinib against the LPS-induced ALI. This effect can be attributed to nilotinib ability to counteract the inflammatory cells infiltration and hence ROS generation and regulate cytokine effects.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21473879     DOI: 10.1016/j.taap.2011.03.023

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  11 in total

1.  Tetrahydrocoptisine protects rats from LPS-induced acute lung injury.

Authors:  Weifeng Li; Huimin Huang; Xiaofeng Niu; Ting Fan; Hua Hu; Yongmei Li; Huan Yao; Huani Li; Qingli Mu
Journal:  Inflammation       Date:  2014-12       Impact factor: 4.092

2.  Oral administration of Ulmus davidiana extract suppresses interleukin-1β expression in LPS-induced immune responses and lung injury.

Authors:  Kwang-Hyun Park; Eun-Yong Chung; Yu-Na Choi; Hye-Yeon Jang; Jong-Suk Kim; Gi-Beum Kim
Journal:  Genes Genomics       Date:  2019-11-17       Impact factor: 1.839

3.  1,8-cineol attenuates LPS-induced acute pulmonary inflammation in mice.

Authors:  Chunzhen Zhao; Jianbo Sun; Chunyan Fang; Fadi Tang
Journal:  Inflammation       Date:  2014-04       Impact factor: 4.092

4.  Nilotinib, a tyrosine kinase inhibitor exhibits protection against acute pancreatitis-induced lung and liver damage in rats.

Authors:  Manar A Nader; Heba M Wagih
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-12-14       Impact factor: 3.000

Review 5.  Excess cerebral TNF causing glutamate excitotoxicity rationalizes treatment of neurodegenerative diseases and neurogenic pain by anti-TNF agents.

Authors:  Ian A Clark; Bryce Vissel
Journal:  J Neuroinflammation       Date:  2016-09-05       Impact factor: 8.322

6.  Veronicastrum axillare Alleviates Lipopolysaccharide-Induced Acute Lung Injury via Suppression of Proinflammatory Mediators and Downregulation of the NF-κB Signaling Pathway.

Authors:  Quanxin Ma; Kai Wang; Qinqin Yang; Shun Ping; Weichun Zhao; Qiyang Shou; Weimin Zhou; Minli Chen
Journal:  Mediators Inflamm       Date:  2016-11-06       Impact factor: 4.711

7.  Bioactive Components from Qingwen Baidu Decoction against LPS-Induced Acute Lung Injury in Rats.

Authors:  Qi Zhang; Hai-Min Lei; Peng-Long Wang; Zhi-Qiang Ma; Yan Zhang; Jing-Jing Wu; Jing Nie; Su-Juan Chen; Wen-Jie Han; Qing Wang; Dan-Yang Chen; Cheng-Ke Cai; Qiang Li
Journal:  Molecules       Date:  2017-04-26       Impact factor: 4.411

8.  Protective effects of ethyl gallate and pentagalloylglucose, the active components of Qingwen Baidu Decoction, against lipopolysaccharide-induced acute lung injury in rats.

Authors:  Qi Zhang; Jing Nie; Su-Juan Chen; Qiang Li
Journal:  Drug Des Devel Ther       Date:  2018-12-19       Impact factor: 4.162

9.  Effects of indole alkaloids from leaf of Alstonia scholaris on post-infectious cough in mice.

Authors:  Yun-Li Zhao; Zi-Feng Yang; Jian-Hua Shang; Wan-Yi Huang; Bei Wang; Xin Wei; Afsar Khan; Zhi-Wei Yuan; Ya-Ping Liu; Yi-Fen Wang; Xin-Hua Wang; Xiao-Dong Luo
Journal:  J Ethnopharmacol       Date:  2018-02-26       Impact factor: 4.360

10.  Effect of tyrosine kinase inhibitors, imatinib and nilotinib, in murine lipopolysaccharide-induced acute lung injury during neutropenia recovery.

Authors:  In Kyoung Kim; Chin Kook Rhee; Chang Dong Yeo; Hyeon Hui Kang; Dong Gun Lee; Sang Haak Lee; Jin Woo Kim
Journal:  Crit Care       Date:  2013-06-20       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.